Infected cyst in patients with autosomal dominant polycystic kidney disease: Analysis of computed tomographic and ultrasonographic imaging features
J Oh, CI Shin, SY Kim - PLoS One, 2018 - journals.plos.org
Purpose To investigate the imaging features of cyst infection in autosomal dominant
polycystic kidney disease (ADPKD) patients using computed tomography (CT) and …
polycystic kidney disease (ADPKD) patients using computed tomography (CT) and …
Complex liver cysts in autosomal dominant polycystic kidney disease
Purpose To determine prevalence of complex liver cysts in Autosomal Dominant Polycystic
Kidney Disease (ADPKD). Methods Abdominal MRI in 186 ADPKD subjects were evaluated …
Kidney Disease (ADPKD). Methods Abdominal MRI in 186 ADPKD subjects were evaluated …
[HTML][HTML] Factors associated with the development and severity of polycystic liver in patients with autosomal dominant polycystic kidney disease
Y Kim, HC Park, H Ryu, YC Kim, C Ahn… - Journal of Korean …, 2023 - synapse.koreamed.org
Background Factors related to the development and severity of polycystic liver disease
(PLD) have not been well established. We aimed to evaluate the genetic and epidemiologic …
(PLD) have not been well established. We aimed to evaluate the genetic and epidemiologic …
Repetitive refractory renal cyst infection in autosomal dominant polycystic kidney disease for which renal transcatheter arterial embolization was effective in preventing …
T Suwabe, M Oguro, Y Ubara, D Ikuma, H Mizuno… - Internal …, 2021 - jstage.jst.go.jp
Renal cyst infection is a frequent and serious complication of autosomal dominant polycystic
kidney disease (ADPKD) that is often difficult to treat and can be fatal. While nephrectomy is …
kidney disease (ADPKD) that is often difficult to treat and can be fatal. While nephrectomy is …
International multi-specialty Delphi survey: identification of diagnostic criteria for hepatic and renal cyst infection
MA Lantinga, AJM Darding, RGL de Sévaux, A Alam… - Nephron, 2016 - karger.com
Background: Cyst infection is one of the complications of autosomal dominant polycystic
kidney disease and polycystic liver disease. The diagnosis is typically made on a mix of …
kidney disease and polycystic liver disease. The diagnosis is typically made on a mix of …
Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study
JL Christophe… - Nephrology Dialysis …, 1996 - academic.oup.com
Background The impact of renal and extrarenal manifestations of autosomal dominant
polycystic kidney disease (ADPKD) during chronic haemodialysis (HD) has never been …
polycystic kidney disease (ADPKD) during chronic haemodialysis (HD) has never been …
Managing cyst infections in ADPKD: an old problem looking for new answers
A Alam, RD Perrone - Clinical Journal of the American Society of …, 2009 - journals.lww.com
The clinical determination of an infected kidney cyst may be difficult in a patient with ADPKD.
The typical presentation of fever and abdominal pain carries a broad differential that …
The typical presentation of fever and abdominal pain carries a broad differential that …
Renal infections in autosomal dominant polycystic kidney disease
AH Sklar, RJ Caruana, JE Lammers… - American Journal of …, 1987 - Elsevier
Renal infection is a common occurrence in autosomal dominant polycystic kidney disease
(ADPKD) and often leads to serious complications, including perinephric abscess …
(ADPKD) and often leads to serious complications, including perinephric abscess …
Standardized 4-point scoring scale of [18F]-FDG PET/CT imaging helps in the diagnosis of renal and hepatic cyst infections in patients with autosomal dominant …
S Demuynck, P Lovinfosse, L Seidel… - Clinical Kidney …, 2023 - academic.oup.com
Background Autosomal dominant polycystic kidney disease (ADPKD) is prone to multiple
complications, including cyst infection (CyI). 2-Deoxy-2-[18F] fluoro-d-glucose positron …
complications, including cyst infection (CyI). 2-Deoxy-2-[18F] fluoro-d-glucose positron …
Hepatic cyst infection during use of the somatostatin analog lanreotide in autosomal dominant polycystic kidney disease: an interim analysis of the randomized open …
MA Lantinga, HMA D'Agnolo, NF Casteleijn… - Drug Safety, 2017 - Springer
Abstract Introduction and Aims The DIPAK-1 Study investigates the reno-and
hepatoprotective efficacy of the somatostatin analog lanreotide compared with standard care …
hepatoprotective efficacy of the somatostatin analog lanreotide compared with standard care …